Servier’s medicines are prescribed in 150 countries. The Group’s strategy of establishing local operations enables it to offer therapeutic solutions adapted to the specific characteristics of each country.

 Servier is the second largest French pharmaceutical Group. In France, the Group has its headquarters, two production sites (98% of active ingredients of Servier brand-name medicines are manufactured in France), two R&D centers and an International Center for Therapeutic Research (ICTR).

With this strong local footprint, the Group has a significant industrial and economic impact through its research and production activities. The creation of the future Servier Research & Development Institute in Paris-Saclay confirms its ongoing commitment to local economic development and to supporting the attractiveness of French research.

Coralan 5 Packshot.png